http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2854991-T3
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_67b65f36ea3713df0a0572fb057242bf |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-61 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-646 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-62 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-54 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-62 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-64 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-61 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-385 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-00 |
| filingDate | 2017-09-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2021-09-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d0771ef84f0c785f89de56df9f0cba9e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d653dfe234f63a62f488f880531b9233 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9214fa2b160580fdbdd692026e389f6c |
| publicationDate | 2021-09-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | ES-2854991-T3 |
| titleOfInvention | Peptide compounds and therapeutic uses thereof |
| abstract | A compound of formula (I) or a pharmaceutically acceptable salt thereof: ** (See formula) ** in which: L represents a binding moiety selected from a cationic antimicrobial peptide linked to X1 by an amine; S1 represents a bond or a spacer selected from a group - (CH2) a- or - (CH2) b- (CH2-CH2-O) c- (CH2) d, wherein one to five of said -CH2- groups they may be optionally substituted by a -C (O) NH- or -NHC (O) - group; a represents an integer selected from 1 to 40; b represents an integer selected from 0 to 25; c represents an integer selected from 1 to 20; d represents an integer selected from 1 to 15; S2 represents a spacer selected from a group - (CH2) e- or - (CH2) f- (CH2-CH2-O) 9- (CH2) h-, in which one to three of said -CH2- groups may be optionally substituted by a -C (O) NH- or -NHC (O) - group; e represents an integer selected from 1 to 20; f represents an integer selected from 1 to 10; g represents an integer selected from 1 to 15; h represents an integer selected from 1 to 5; X1 represents a bond or -C (O) -; Y1 and Y2 independently represent a bond, group -O-, -S-, -NH-, -C (O) -, -NHC (O) - or -C (O) NH-; F represents a carbohydrate molecule capable of binding to a human anti-alpha-galactosyl antibody; m represents an integer selected from 1 to 5; and Cy represents phenyl, biphenyl or triphenyl, such that when Cy represents biphenyl or triphenyl, said -Y1-S1-X1-L group can be present in any of said phenyl rings and said group or groups [F-S2-Y2 ] m can be present on any such phenyl ring. |
| priorityDate | 2016-09-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 40.